Previous close | 16.36 |
Open | 16.36 |
Bid | 16.00 x 0 |
Ask | 16.10 x 0 |
Day's range | 15.95 - 16.95 |
52-week range | 14.40 - 70.51 |
Volume | |
Avg. volume | 42,214 |
Market cap | 127.59M |
Beta (5Y monthly) | 0.48 |
PE ratio (TTM) | 0.16 |
EPS (TTM) | 100.95 |
Earnings date | 17 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 60.00 |
CLS’s Single-Use, Sterile Instruments to be used in Research Study - MRI/Ultrasound Fusion-Guided FLA of Prostate Tissue and Prostate CancerLOS ANGELES, April 09, 2024 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced it has received its second order from the National Institutes of Health Clinical Center (NIHCC) for its TRANBERG™ Thermal Therapy System accessories. This or
High Precision System Uses Image Guidance to Target Tumor, Preserve Healthy Tissue & Reduce Risks of Complications such as EDLOS ANGELES, March 28, 2024 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced that ROSE Urology, LLC, located in Vero Beach, Florida, will begin using the TRANBERG™ Thermal Therapy System to treat prostate cancer patients. The TRANBERG system is desi
CLS Partners with World Class Aftermarket Services Company to Meet Strong Growth and Maximize Market PenetrationLOS ANGELES, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced it has selected Quest International, a global aftermarket technical service provider to OEMs, to provide Service and Logistics Operations for the US market. Under the agreement, Quest wi